Europe’s Gold Standard Event for Pharma & Biotech Patent Litigation
C5’s Pharma & Biotech Patent Litigation in Europe Forum brings together top litigators, government, industry associations and in-house counsel to explore the latest legal and regulatory developments impacting the life sciences industry.
Attend and gain practical insights on the UPC’s evolving jurisprudence, international and national European patent litigation strategies, and the EU’s regulatory changes.
Join us for two days of engagement with the European life sciences patent bar and shape the future of pharma and biotech litigation.
Complimentary Webinar
Preliminary Forum Selection Insights & Strategies
16 April | 1:00 – 2:00 pm CET
Learn More
Liz Cohen
Partner
Bristows LLP
Gertjan Kuipers
Partner
Hogan Lovells
Dr. Kai Rüting, LL.M.
Partner | UPC Representative
Vossius & Partner
Conference Co-Chairs
Our distinguished co-chairs share their thoughts on why this year’s Forum on Pharma & Biotech Patent Litigation in Europe in Amsterdam is a must-attend event.
Liz Cohen
Partner
Bristows LLP
“I’m very much looking forward to co-chairing and speaking at this year’s conference. With an engaging agenda and expert speakers, it promises to be another excellent event.”
Dr. Kai Rüting, LL.M.
Partner | UPC Representative
Vossius & Partner
“This conference is a great forum for cross-border life sciences litigation updates. This year will be exceptional as we discuss the first pharma and biotech decisions of the Unified Patent Court with in-house counsel, litigators, and judges.”
Ruud van der Velden
Partner
Hogan Lovells
“The conference promises to be a fantastic event with discussions on national courts, the EPO, the UPC, regulation reforms, and public policy. I look forward to co-chairing, reconnecting with familiar faces, and engaging in insightful debates!”
UPC Judges & Government Speakers
Peter Blok
Presiding Judge
UPC, Court of Appeal, the Hague
Edger F. Brinkman
Presiding Judge
UPC LD the Hague, the Netherlands
Senior Judge
Court of the Hague, the Netherlands
Boris Andrejaš
Case Handler
European Commission
DG Comp
Dr. Martijn de Lange
Patent Examiner
Netherlands Patent Office
Dr. Sönke Holtorf
Director, Biotechnology
European Patent Office
Attend to Gain Insights, Global Perspectives and Develop Winning Strategies.
Our Stellar Faculty Will Help You:
Analyze the emerging litigation trends in the UPC and national courts
Engage with Judges from the UPC
Demystify forum selection and parallel proceedings
Navigate the evolving EU regulatory landscape and its impact on IP
Adapt to EU competition law enforcement trends and cadence
Fine-tune your SPC strategies in the EU and the UK
Who Should Attend
In-Housel Counsel and Executives from Pharmaceutical and Biotech Companies, including:
- Head of IP
- Head of Patent Litigation
- VP-Intellectual property
- Scientific Director
- Head of Legal / Legal Affairs
- Principal Patent Examiner
- Head of Global Strategy
- Director Innovation, IP and Portfolio Management
- R&D Patent manager
- Associate VP & Director of Technology Licensing & Commercialization
- Patent Counsel
Law firm attorneys with
practices in:
- Intellectual Property and Patent Law
- Life Sciences
- European Patent Law
- US Patent
“The combination of networking opportunities with people from various backgrounds. Concise overview over the most relevant topics.”
“Good networking opportunities with in-house Counsel and leading IP law firms. Hot topics, great speakers and convenient number of attendants.”
“Important subject matters to discuss presented by renowned specialists. An important conference to attend.”
Sponsor Opportunities
With conferences in the United States, Europe, Asia Pacific, and Latin America, the C5 Group of Companies: American Conference Institute, the Canadian Institute, and C5 Group, provides a diverse portfolio of conferences, events and roundtables devoted to providing business intelligence to senior decision makers responding to challenges around the world.
For more information please contact:
Aaron Goldstein
Senior Business Development Manager
Email: [email protected]
